Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Wnt Signaling
63%
Colon Cancer
61%
Wnt Signaling Pathway
50%
Levamisole
44%
Chediak-Higashi Syndrome
38%
Care Coordination
35%
Wnt Ligands
34%
5-fluorouracil (5-FU)
34%
In Cancer
28%
Beta-catenin
28%
Cancer Patients
28%
Resveratrol
26%
T Cells
25%
Metastatic Colorectal Cancer (mCRC)
25%
Tumor
25%
Tumor Microenvironment
24%
Peripheral Blood Mononuclear Cells
24%
Clinical Trials
24%
Colon
23%
New York City
23%
Inflammatory Bowel Disease
22%
Southwest Oncology Group
22%
Patient Perception
22%
Rural Patients
21%
Gemcitabine
20%
Colon Adenocarcinoma
20%
Interleukin-2
19%
LEF1
19%
Wnt Genes
19%
Genistein
19%
Cancer Care Coordination
18%
Signaling Pathway
18%
Cancer Care
18%
Wnt2
18%
LAMP2
18%
Colonic mucosa
17%
Colon Surgery
17%
Frizzled Receptors
17%
Cyclophosphamide
17%
Cancer Clinical Trials
17%
Stage III Colon Cancer
17%
Clinical Research
15%
Natural Killer Cells
15%
Chemotherapy
15%
Wnt Antagonists
15%
Oncohematology
15%
Chromosome 13
15%
Immunomodulation
15%
Group Studies
15%
Cholangiocarcinoma
15%
Medicine and Dentistry
Malignant Neoplasm
100%
Oncology
70%
Wnt Signaling
43%
Cancer
35%
Care Coordination
34%
Colon Carcinoma
33%
Hematology
30%
Clinical Trial
28%
Diseases
26%
Cholangiocarcinoma
22%
Patient Satisfaction
22%
Chemotherapy
19%
Health Care Personnel
19%
Carcinogenesis
17%
Resveratrol
17%
Therapeutic Target
17%
Levamisole
15%
Health Care Cost
15%
Tumor Microenvironment
15%
Liver Tumor
15%
Colorectal Carcinoma
15%
Tumor
15%
Clinical Research
14%
Radiation Therapy
13%
Cancer Prevention
12%
Gemcitabine
12%
Overall Survival
12%
Colon Mucosa
12%
Cancer Therapy
11%
Granulocyte
11%
Neoplasm
11%
Gastroesophageal Junction
11%
Interleukin 2
11%
Prescription Medication
11%
Tumor Cell
11%
Medicaid
10%
Granulocytopenia
10%
Outpatient
9%
Anticarcinogen
9%
Tubular Adenoma
9%
Tumor Biology
9%
Villous Adenoma
9%
Analgesia
9%
Chemoradiotherapy
9%
Abdominal Cancer
9%
Adenoma
9%
Immunohistochemistry
9%
Gene Expression
8%
Health System
8%
Education
8%